{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:38:26Z","timestamp":1792809506425,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Kitto Life Co. Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s40123-026-01509-8","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:16:20Z","timestamp":1791206180000},"page":"3869-3886","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects and Safety of Grape Skin Enzyme Fermentation Extract for Eye Fatigue and Dry Eye Symptoms: An Exploratory Randomized Controlled Trial"],"prefix":"10.1007","volume":"15","clinical-trial-number":[{"clinical-trial-number":"kct0012279","registry":"10.18810\/cris"}],"author":[{"given":"Hoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Pil","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1468-467X","authenticated-orcid":false,"given":"Kyongjin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"issue":"3","key":"1509_CR1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334\u201365.","journal-title":"Ocul Surf"},{"issue":"3","key":"1509_CR2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276\u201383.","journal-title":"Ocul Surf"},{"issue":"23","key":"1509_CR3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239271","volume":"21","author":"K Tsubota","year":"2020","unstructured":"Tsubota K, Pflugfelder SC, Liu Z, et al. Defining dry eye from a clinical perspective. Int J Mol Sci. 2020;21(23):9271.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1509_CR4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archophthalmol.2011.78","volume":"129","author":"SB Han","year":"2011","unstructured":"Han SB, Hyon JY, Woo SJ, Lee JJ, Kim TH, Kim KW. Prevalence of dry eye disease in an elderly Korean population. Arch Ophthalmol. 2011;129(5):633\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"1509_CR5","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ajo.2014.08.021","volume":"158","author":"JM Ahn","year":"2010","unstructured":"Ahn JM, Lee SH, Rim TH, et al. Prevalence of and risk factors associated with dry eye: the Korea National Health and Nutrition Examination Survey 2010\u20132011. Am J Ophthalmol. 2010;158(6):1205-1214.e7.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1509_CR6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ICO.0b013e3181f7f363","volume":"30","author":"J Yu","year":"2011","unstructured":"Yu J, Asche CV, Fairchild CJ. The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea. 2011;30(4):379\u201387.","journal-title":"Cornea"},{"issue":"2","key":"1509_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40135-013-0009-1","volume":"1","author":"M Uchino","year":"2013","unstructured":"Uchino M, Schaumberg DA. Dry eye disease: impact on quality of life and vision. Curr Ophthalmol Rep. 2013;1(2):51\u20137.","journal-title":"Curr Ophthalmol Rep"},{"issue":"3","key":"1509_CR8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575\u2013628.","journal-title":"Ocul Surf"},{"key":"1509_CR9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ajo.2025.05.039","volume":"279","author":"L Jones","year":"2025","unstructured":"Jones L, Craig JP, Markoulli M, et al. TFOS DEWS III: management and therapy. Am J Ophthalmol. 2025;279:289\u2013386.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1509_CR10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"C Baudouin","year":"2010","unstructured":"Baudouin C, Labb\u00e9 A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29(4):312\u201334.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"1509_CR11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","volume":"5","author":"MA Lemp","year":"2007","unstructured":"Lemp MA, Baudouin C, Baum J, et al. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007;5(2):75\u201392.","journal-title":"Ocul Surf"},{"issue":"6","key":"1509_CR12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/ICL.0000000000001086","volume":"50","author":"CB Nau","year":"2024","unstructured":"Nau CB, Nau AC, Fogt JS, Harthan JS, Shorter ES, Schornack MM. Patient-reported dry eye treatment and burden of care. Eye Contact Lens. 2024;50(6):259\u201364.","journal-title":"Eye Contact Lens"},{"issue":"2","key":"1509_CR13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11020367","volume":"11","author":"M Uchino","year":"2022","unstructured":"Uchino M, Yokoi N, Shimazaki J, Hori Y, Tsubota K. Adherence to eye drops usage in dry eye patients and reasons for non-compliance: a web-based survey. J Clin Med. 2022;11(2):367.","journal-title":"J Clin Med"},{"issue":"1","key":"1509_CR14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2018-000146","volume":"3","author":"AL Sheppard","year":"2018","unstructured":"Sheppard AL, Wolffsohn JS. Digital eye strain: prevalence, measurement and amelioration. BMJ Open Ophthalmol. 2018;3(1):e000146.","journal-title":"BMJ Open Ophthalmol"},{"issue":"5","key":"1509_CR15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/OPX.0b013e31828f09a7","volume":"90","author":"JK Portello","year":"2013","unstructured":"Portello JK, Rosenfield M, Chu CA. Blink rate, incomplete blinks and computer vision syndrome. Optom Vis Sci. 2013;90(5):482\u20137.","journal-title":"Optom Vis Sci"},{"issue":"3","key":"1509_CR16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clae.2015.01.007","volume":"38","author":"R Bhargava","year":"2015","unstructured":"Bhargava R, Kumar P, Phogat H, Kaur A, Kumar M. Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye. Contact Lens Anterior Eye. 2015;38(3):206\u201310.","journal-title":"Contact Lens Anterior Eye"},{"issue":"4","key":"1509_CR17","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1111\/aos.13526","volume":"96","author":"S Seen","year":"2018","unstructured":"Seen S, Tong L. Dry eye disease and oxidative stress. Acta Ophthalmol. 2018;96(4):e412\u201320.","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"1509_CR18","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/ICO.0000000000000940","volume":"35","author":"AT Epitropoulos","year":"2016","unstructured":"Epitropoulos AT, Donnenfeld ED, Shah ZA, et al. Effect of oral re-esterified omega-3 nutritional supplementation on dry eyes. Cornea. 2016;35(9):1185\u201391.","journal-title":"Cornea"},{"issue":"8","key":"1509_CR19","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1111\/aos.13428","volume":"95","author":"I Molina-Leyva","year":"2017","unstructured":"Molina-Leyva I, Molina-Leyva A, Bueno-Cavanillas A. Efficacy of nutritional supplementation with omega-3 and omega-6 fatty acids in dry eye syndrome: a systematic review of randomized clinical trials. Acta Ophthalmol. 2017;95(8):e677\u201385.","journal-title":"Acta Ophthalmol"},{"key":"1509_CR20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.food.080708.100754","volume":"1","author":"J He","year":"2010","unstructured":"He J, Giusti MM. Anthocyanins: natural colorants with health-promoting properties. Annu Rev Food Sci Technol. 2010;1:163\u201387.","journal-title":"Annu Rev Food Sci Technol"},{"issue":"5","key":"1509_CR21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/1541-4337.12024","volume":"12","author":"E Pojer","year":"2013","unstructured":"Pojer E, Mattivi F, Johnson D, Stockley CS. The case for anthocyanin consumption to promote human health: a review. Compr Rev Food Sci Food Saf. 2013;12(5):483\u2013508.","journal-title":"Compr Rev Food Sci Food Saf"},{"issue":"2","key":"1509_CR22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.canlet.2008.05.020","volume":"269","author":"LS Wang","year":"2008","unstructured":"Wang LS, Stoner GD. Anthocyanins and their role in cancer prevention. Cancer Lett. 2008;269(2):281\u201390.","journal-title":"Cancer Lett"},{"issue":"6","key":"1509_CR23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1079\/BJN20041126","volume":"91","author":"CD Kay","year":"2004","unstructured":"Kay CD, Mazza G, Holub BJ, Wang J. Anthocyanin metabolites in human urine and serum. Br J Nutr. 2004;91(6):933\u201342.","journal-title":"Br J Nutr"},{"issue":"4","key":"1509_CR24","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3109\/03602532.2014.978080","volume":"46","author":"J Fang","year":"2014","unstructured":"Fang J. Bioavailability of anthocyanins. Drug Metab Rev. 2014;46(4):508\u201320.","journal-title":"Drug Metab Rev"},{"issue":"1","key":"1509_CR25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/mnfr.201100526","volume":"56","author":"T Tsuda","year":"2012","unstructured":"Tsuda T. Dietary anthocyanin-rich plants: biochemical basis and recent progress in health benefits studies. Mol Nutr Food Res. 2012;56(1):159\u201370.","journal-title":"Mol Nutr Food Res"},{"issue":"17","key":"1509_CR26","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1021\/jf205321j","volume":"60","author":"JW Hwang","year":"2012","unstructured":"Hwang JW, Kim EK, Lee SJ, et al. Antioxidant activity and protective effect of anthocyanin oligomers on H2O2-triggered G2\/M arrest in retinal cells. J Agric Food Chem. 2012;60(17):4282\u20138.","journal-title":"J Agric Food Chem"},{"issue":"6","key":"1509_CR27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1079\/BJN20051438","volume":"93","author":"J Lee","year":"2005","unstructured":"Lee J, Lee HK, Kim CY, et al. Purified high-dose anthocyanoside oligomer administration improves nocturnal vision and clinical symptoms in myopia subjects. Br J Nutr. 2005;93(6):895\u20139.","journal-title":"Br J Nutr"},{"issue":"10","key":"1509_CR28","first-page":"2518","volume":"21","author":"A Riva","year":"2017","unstructured":"Riva A, Togni S, Franceschi F, et al. The effect of a natural, standardized bilberry extract (Mirtoselect\u00ae) in dry eye: a randomized, double-blinded, placebo-controlled trial. Eur Rev Med Pharmacol Sci. 2017;21(10):2518\u201325.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"1509_CR29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/ceo.14207","volume":"51","author":"M Fan","year":"2023","unstructured":"Fan M, Kim SA, Choi YJ, Tang Y, Yang HP, Kim EK. Anthocyanin oligomer (grape skin extract) administration improves dry eye disease: a randomised, double-blind, placebo-controlled study. Clin Exp Ophthalmol. 2023;51(2):122\u201330.","journal-title":"Clin Exp Ophthalmol"},{"key":"1509_CR30","unstructured":"Ministry of Food and Drug Safety, National Institute of Food and Drug Safety Evaluation. Health Functional Food Functional Evaluation Guide (Eye Health Related). Guideline No. 0129-03. Cheongju: Ministry of Food and Drug Safety; 2026. https:\/\/www.mfds.go.kr\/brd\/m_1060\/view.do?seq=15859. Accessed August 8, 2026."},{"issue":"3","key":"1509_CR31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539\u201374.","journal-title":"Ocul Surf"},{"issue":"4","key":"1509_CR32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.clae.2015.03.001","volume":"38","author":"JS Wolffsohn","year":"2015","unstructured":"Wolffsohn JS, Naroo SA, Christie C, et al. Anterior eye health recording. Contact Lens Anterior Eye. 2015;38(4):266\u201371.","journal-title":"Contact Lens Anterior Eye"},{"issue":"5","key":"1509_CR33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118(5):615\u201321.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"1509_CR34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.OPX.0000156307.95086.6","volume":"82","author":"SL Ames","year":"2005","unstructured":"Ames SL, Wolffsohn JS, McBrien NA. The development of a symptom questionnaire for assessing virtual reality viewing using a head-mounted display. Optom Vis Sci. 2005;82(3):168\u201376.","journal-title":"Optom Vis Sci"},{"issue":"3","key":"1509_CR35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jtcme.2018.11.001","volume":"9","author":"S Yamashita","year":"2019","unstructured":"Yamashita S, Suzuki N, Yamamoto K, Iio S, Yamada T. Effects of MaquiBright\u00ae on improving eye dryness and fatigue in humans: a randomized, double-blind, placebo-controlled trial. J Tradit Complement Med. 2019;9(3):172\u20138.","journal-title":"J Tradit Complement Med"},{"issue":"3 Suppl 1","key":"1509_CR36","first-page":"1","volume":"56","author":"S Hitoe","year":"2014","unstructured":"Hitoe S, Tanaka J, Shimoda H. MaquiBright\u00ae standardized maqui berry extract significantly increases tear fluid production and ameliorates dry eye-related symptoms in a clinical pilot trial. Panminerva Med. 2014;56(3 Suppl 1):1\u20136.","journal-title":"Panminerva Med"},{"issue":"4","key":"1509_CR37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/pst.185","volume":"4","author":"SA Julious","year":"2005","unstructured":"Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4(4):287\u201391.","journal-title":"Pharm Stat"},{"issue":"3","key":"1509_CR38","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1177\/0962280215588241","volume":"25","author":"AL Whitehead","year":"2016","unstructured":"Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016;25(3):1057\u201373.","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"1509_CR39","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00003226-200404000-00010","volume":"23","author":"KK Nichols","year":"2004","unstructured":"Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea. 2004;23(3):272\u201385.","journal-title":"Cornea"},{"issue":"4","key":"1509_CR40","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1167\/iovs.06-1027","volume":"48","author":"S Nakamura","year":"2007","unstructured":"Nakamura S, Shibuya M, Nakashima H, et al. Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye. Invest Ophthalmol Vis Sci. 2007;48(4):1552\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1509_CR41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/aos.13436","volume":"96","author":"C Baudouin","year":"2018","unstructured":"Baudouin C, Irke\u00e7 M, Messmer EM, et al. Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting. Acta Ophthalmol. 2018;96(2):111\u20139.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"1509_CR42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archophthalmol.2009.356","volume":"128","author":"KL Miller","year":"2010","unstructured":"Miller KL, Walt JG, Mink DR, et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol. 2010;128(1):94\u2013101.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"1509_CR43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","volume":"100","author":"C Baudouin","year":"2016","unstructured":"Baudouin C, Messmer EM, Aragona P, et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. 2016;100(3):300\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"1509_CR44","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1167\/iovs.05-1504","volume":"47","author":"A Tomlinson","year":"2006","unstructured":"Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci. 2006;47(10):4309\u201315.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"1509_CR45","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.ophtha.2015.08.001","volume":"122","author":"J Tauber","year":"2015","unstructured":"Tauber J, Karpecki P, Latkany R, et al. Lifitegrast ophthalmic solution 5.0% versus placebo for treatment of dry eye disease: results of the randomized phase III OPUS-2 study. Ophthalmology. 2015;122(12):2423\u201331.","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01509-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01509-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01509-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:01:42Z","timestamp":1792807302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01509-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1509"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01509-8","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"7 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Hyun Pil Yang is an employee of Kitto Life Co., Ltd., which funded the study and supplied the investigational product and matching placebo. Hoon Kim, Yuli Park, and Kyongjin Cho declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Dankook University Hospital (DKUH IRB 2025-02-007) and was conducted in accordance with the Declaration of Helsinki and the Korean Good Clinical Practice Guidelines. Written informed consent was obtained from all participants before enrollment. The trial was retrospectively registered with the Clinical Research Information Service (CRIS; KCT0012279) on 14 July 2026, after participant enrollment and study completion, because the investigators had misunderstood the timing requirement for clinical trial registration and believed that registration before manuscript submission was sufficient after institutional ethics approval. To mitigate concerns arising from retrospective registration, the manuscript clearly distinguishes protocol-specified analyses from post hoc analyses, explicitly states that the study protocol did not define a formal hierarchy among efficacy outcomes or a multiplicity-control framework, and consistently interprets the efficacy findings as exploratory rather than confirmatory.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}